Grants for Nonprofits - Health

This funding opportunity supports the development of biomedical research networks in underfunded states and territories, enhancing research capacity and collaboration among colleges and universities, particularly those serving undergraduate students.

The purpose of this NOFO is to invite grant applications that support healthcare safety by determining (1) whether and how certain breakthrough uses of Artificial Intelligence (AI) systems can affect patient safety; and (2) how AI systems can be safely implemented and used. AI has the potential to improve the safety, effectiveness, efficiency, accessibility, and affordability of healthcare. However, as with most technologies, this potential must be balanced by identifying and mitigating potential risks for patient harm and user burden.

The City of Oakley's Small Business Grant Program aims to bolster local businesses that have faced challenges due to the COVID-19 pandemic and economic shifts. This initiative directly aligns with a broader mission to foster a resilient local economy and support the foundational stability of small enterprises within the community. By offering financial assistance, the program seeks to mitigate the adverse effects experienced by businesses, helping them to navigate market fluctuations and maintain operational health. The primary beneficiaries of this grant are small businesses located within Oakley City Limits, holding a valid City of Oakley Business License, and employing fewer than 25 individuals. The program specifically targets private corporations, LLCs, and similar entities that can demonstrate financial hardship directly attributable to the pandemic, while excluding publicly traded companies. The impact goals are centered on ensuring the survival and sustained operation of these businesses, thereby preserving local jobs and maintaining essential services within the community. The program prioritizes businesses based on their annual revenue in either 2020 or 2021, categorizing them into two tiers. Businesses with an annual revenue of less than $100,000 are eligible for a $2,500 grant, recognizing their potentially more acute needs. Those with an annual revenue of $100,000 or more can receive a $5,000 grant, acknowledging their greater operational requirements and significant contributions to the local economy. This tiered approach ensures that support is proportionally distributed based on a business's economic scale and impact. Grant funds are designed to cover essential business expenses, offering flexibility to address immediate needs. Permitted uses include implementing safety protocols, covering rent and utilities, retaining employees, and investing in marketing and promotional activities. The expected outcomes include enhanced business stability, a reduction in business closures, and the preservation of local employment. Measurable results would involve tracking the number of businesses supported, the types of expenses covered, and the overall economic health indicators of participating businesses. The strategic priority is to build a stronger, more stable local business environment, with a theory of change rooted in the idea that targeted financial support can directly enable small businesses to overcome economic shocks and contribute to long-term community prosperity.

(Reissue of PAR-18-490) The purpose of the NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01) is to diversify the pool of independent neuroscience research investigators by providing junior faculty with research cost support, protected research time and career stage appropriate professional development mentorship in neuroscience research. Individuals from backgrounds underrepresented in biomedical research are eligible for support under this award if they have doctoral research degrees (Ph.D. or equivalent) and are in the first 3 years of a faculty tenure track or equivalent position at the time of application. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.

This grant provides funding to establish state-based cooperatives that will improve behavioral healthcare for medically underserved populations by implementing patient-centered improvements based on evidence from patient-centered outcomes research.

This funding opportunity provides financial support for innovative research aimed at understanding the brain mechanisms behind substance use disorders, targeting a wide range of applicants including universities, nonprofits, and private organizations.

The Alfred E. Alquist Hospital Facilities Seismic Safety Act (Health and Safety Code (HSC) Section 129675) requires that hospitals be constructed to remain open and safely provide services to the public after an earthquake. The Small and Rural Hospital Relief Program will administer this new grant program to eligible small, rural, or Critical Access hospitals that have limited funds for seismic safety retrofit requirements. Ten percent of the funds from the California Electronic Cigarette Excise Tax will be allocated to HCAI to fund the new program (HSC Section 130075). The SRHRP supports qualified small, rural and Critical Access hospitals by providing state grant funding and technical assistance to help meet seismic safety standards and preserve access to general acute care for the communities they serve. The program is being developed to assist qualified facilities with technical assistance for development of seismic improvement program planning, project planning and development, and financial grants to apply towards implementing each facility’s unique compliance program. The first step in qualifying for the program will be the application process, which will be used to determine if facilities meet the qualifications as either a small, rural or Critical Access hospital at risk of closure for financial reasons. Program applicants will be required to have current seismic compliance plans and agreed-upon project delivery plans on file with HCAI’s Seismic Compliance Unit prior to acceptance of funding package applications. A process will be employed to optimize use of available funds across all program participants based on need and adherence to approved project schedules.

This funding opportunity announcement (FOA) invites research projects that seek to explain the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in human health, illness, recovery, and overall wellbeing. Types of projects submitted under this FOA include mechanistic studies that are classified as clinical trials. Mechanistic studies are defined as studies with the objective to understand the mechanism(s) of action of an intervention, a biological or behavioral process, or the pathophysiology of a disease/condition. See NOT-AT-20-001 and NOT-MH-19-006 for examples of clinical trials that are/are not considered mechanistic studies. Clinical trials that propose to influence a clinical outcome, test safety or feasibility of an intervention, demonstrate the clinical efficacy or effectiveness of an intervention, or analyze the effect size of an intervention on clinical outcomes are ineligible for this FOA. Types of studies that should submit under this FOA include clinical trials that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of phenomena without specific application towards processes or products in mind. Researchers proposing basic science experimental studies involving human participants should consider this FOAs companion for basic experimental studies with humans, TEMP-14931, Research on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required). Applications proposing studies that include, but are not limited to, model animal research or observational studies involving humans should submit under the companion FOA, TEMP-14934, "Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed).

This funding opportunity provides financial support to eligible agencies in Ohio to implement programs and strategies aimed at reducing fall-related injuries and deaths among older adults.

Adolescence is a critical risk period for substance use initiation and adverse outcomes related to substance use, particularly as drug use has been found to escalate between ages 12 and 19. The goal of substance use prevention efforts is to prevent and/or delay the first use of substances. Research shows that early age of onset is an important predictor for the development of a substance use disorder later in life. Further, research shows that prevention interventions can have positive long-term effects in reducing substance use. Recognizing that preventing or delaying initiation of substance use can confer important health and social benefits, the purpose of the NCI is to serve as the training and technical assistance partner for DFC and non-DFC funded community coalitions across the country by enhancing the capacity of the prevention workforce and others in the prevention community to implement evidence-based interventions.

This grant provides funding for interdisciplinary research teams to develop innovative strategies for preventing and treating infections caused by antibiotic-resistant bacteria.

This funding opportunity supports nonprofit and public sector programs in specific Ohio counties that promote successful children, healthy families, self-sufficient residents, and strong communities.

This funding opportunity supports community-based organizations conducting research to improve health equity for Indigenous and historically marginalized communities of color in the U.S.

This funding opportunity supports research projects that combine imaging techniques and liquid biopsies to improve cancer treatment monitoring and response assessment in clinical settings.

This funding opportunity supports Delaware-based organizations in raising public awareness about the health risks and environmental impacts of PFAS chemicals, particularly in disadvantaged communities.

This funding opportunity provides financial support for nonprofit organizations and government entities in New York State to conduct impactful research addressing health disparities related to HIV, hepatitis C, STIs, drug user health, and LGBTQ+ issues.

This project seeks to further refine and geographically expand a methodology for obtaining drug early warning indicators through broader testing of urine samples that were previously collected and tested as part of an existing drug test protocol. This method was initially developed using local criminal justice populations including persons in pre-trial or lock-up, parolees or probationers, and drug court participants. A similar methodology is promising for use in other venues, such as in trauma units and emergency departments, where biological samples are often collected from patients. Before the specimens are discarded, the project will re-test them for an expanded panel of drugs, including xylazine, fentanyl, methamphetamine, and other new psychoactive substances (NPS); to determine what old and new illicit drugs are detected or missed by conventional testing protocols, and how the drug patterns might vary by subpopulation and geography. Bypassing the expense of collecting the original specimens and re-using those that have already been tested with known results yields a relatively inexpensive and timely picture of emerging drugs in a given subpopulation and locality. Hospital and de-identified nationally representative patient electronic health records (EHRs) should be collected and analyzed to put re-tested urine positivity results into a larger regional and national context of drug exposure and consequences. ONDCP is seeking to apply this testing methodology and insight from supplemental EHR investigations to emergency department and other hospital-system populations in locations throughout the United States to reinforce best practice guidelines, testing standardization, and build local and national surveillance capacity.

This funding opportunity supports early-stage research to develop new therapeutic agents for heart, lung, blood, and sleep disorders, specifically targeting projects that have identified promising small molecules or biologics ready for preclinical testing.

The Metastasis Research Network (MetNet) Research Projects grant aims to fund research projects that use comprehensive, systems-level approaches to address gaps in metastasis research, particularly focusing on themes like dormancy, early dissemination, and cellular or physical microenvironment interactions, with the goal of enhancing our understanding of metastasis as a whole-body, systems-level issue.

Matching Grants are designed to leverage funding by matching other grants or funding already secured by organizations. These are part of the Legacy Foundation's efforts to maximize impact on health improvements in the lower Rio Grande area. Interested organizations must contact the Foundation for specific application instructions. Grant renewed every year. Grant Annual Spring opening/closing deadlines: February 15th to May 1st. LOI: March 20th